Posted inBiotechnology
Attovia files for IPO to take on Sanofi and Regeneron’s Dupixent
Attovia Therapeutics has filed for an IPO to secure funding for assets including a potential challenger to Sanofi and Regeneron’s…
Posted inBiotechnology
New insights may improve the quality of 3D-printed aluminum components
Scientists at The University of Manchester report that even modest temperature variations during molten metal deposition (MMD) can reshape the…
Posted inBiotechnology
Ulinastatin Shows Therapeutic Effects in Liver Diseases
Sepsis, major surgery, drug exposure, viruses, and long-term illnesses all converge on the liver—an organ central to nutrient metabolism, detoxification,…
Posted inBiotechnology
Emergency High-Risk Surgery Costs Older Adults a Month of Home Time
Older adults who undergo high-risk emergency abdominal surgery may spend far less time living independently at home in the year…
Posted inBiotechnology
Osteocyte Parvalbumin Drives Mechanotransduction to Reduce Osteoarthritis Progression
A new study published in Nature Communications (2026) spotlights an unexpected molecular player in the battle against osteoarthritis: osteocyte parvalbumin.…
Posted inBiotechnology
Slow-Speed Protocol Tests Remote Exercise in Three Randomized Trials to Prevent Parkinson’s
A new set of clinical trials is aiming to answer a deceptively simple question: can exercise delivered at a distance…
Posted inBiotechnology
Screening for Benign Positional Vertigo in Older Patients at Falls Clinics
A new study highlights a largely preventable cause of dizziness in older adults—benign paroxysmal positional vertigo (BPPV)—and argues that falls…
Posted inGenetics
AstraZeneca Licenses Global Rights to Dizal Lung Cancer Drug for Up-to-$1.5B
AstraZeneca has acquired exclusive global rights to develop and commercialize Dizal Pharmaceutical’s marketed lung cancer drug Zegfrovy® (sunvozertinib), through an…
Posted inBiotechnology
Immune Ecotypes Could Account for Multiple Myeloma Outcomes Beyond Staging
Multiple myeloma has long been puzzling: two patients with “the same” diagnosis can diverge dramatically in progression and therapy response.…
Posted inBiotechnology
Karen Bernstein Elected Chair of C-Path Board, Influential Biotech Voice
TUCSON, Ariz., July 14, 2026 — Critical Path Institute® (C-Path) announced that its Board of Directors has elected Karen Bernstein,…